Portfolio Lab

Pfizer Inc

  • Stock
  • Ticker PFE
  • ISIN US7170811035
  • NYSE

Health care · Pharmaceuticals · USA

$27.40 −0.51%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Pfizer Inc since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

PFEGlobal equities (VT)

$10,000 grew to $14,495. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −59.0% in 04/2025, measured from the peak in 12/2021. The old peak has not been reached again yet.

1-year return
+19.9%
5-year return p.a.
−6.7%
10-year return p.a.
+3.8%
Volatility p.a.
23.0%
Largest decline
−59.0%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue17,76313,71514,65316,65417,55714,45115,03416,583
Gross profit11,85410,87010,87512,48212,28510,90310,94212,555
Net income4102,9672,9103,541-1,6482,687-2483,242
Earnings per share0.070.520.510.62-0.290.47-0.040.56
Balance sheet
Total assets213,396208,028206,095208,731208,160207,618201,131204,544
Liabilities124,899117,391117,083115,635121,385117,214115,639115,243
Equity88,20390,33888,69592,80186,47690,10185,19089,001
Cash1,0431,4301,6381,3431,1421,7039761,824
Long-term debt57,40557,63957,50257,40961,64160,56560,49559,997
Cash flow
Operating cash flow6,7212,335-5824,6035,3482,6158355,375
Capital expenditure-917-564-618-602-845-436-533-573
Free cash flow5,8041,771-1,2004,0014,5032,1793024,802

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2021 at +66.7%, weakest 2023 at −41.2%. 5 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
3 Nov 2026$0.56
4 Aug 2026−$0.04
5 May 2026$0.47
26 Feb 2026−$0.29
4 Nov 2025$0.62
5 Aug 2025$0.51
5 May 2025$0.52
27 Feb 2025$0.07
4 Nov 2024$0.78
5 Aug 2024$0.01
8 May 2024$0.55
22 Feb 2024−$0.59

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€142bn
Market cap in trading currency
$156bn
Enterprise value
$208bn
P/E
39.1
P/S
2.45
P/B
1.75
EV/Sales
3.27
EV/EBITDA
15.4
Earnings yield
2.6%
FCF yield
7.5%

Results (last four quarters)

Revenue
$63.6bn
Gross profit
$46.7bn
EBITDA
$13.5bn
Net income
$4.03bn
Earnings per share
$0.70
Revenue per share
$11.16
Revenue growth
−0.4%
Earnings growth
−8.4%

Profitability

Gross margin
73.4%
Operating margin
11.0%
Net margin
6.3%
Return on equity
4.4%
Return on assets
2.0%

Balance sheet and cash flow

Cash
$10.9bn
Cash per share
$1.92
Financial debt
$62.6bn
Debt/equity %
70
Current ratio
1.42
Book value per share
$15.61
Operating cash flow
$14.2bn
Free cash flow
$11.8bn

Dividend

Dividend yield
6.28%
Dividend (12 months)
$1.72
Yield (12 months)
6.28%
Payout ratio
246%
Ex-dividend date
6 Nov 2026

Shares and trading

Shares outstanding
5.70bn
Volume
37.9m
Avg. volume 3 months
33.6m
Relative volume
1.1

Price and technicals

Price
$27.40
1 day
−0.5%
52-week high
$30.79
52-week low
$23.67
Distance to 52-week high
−11.0%
Distance to 52-week low
+15.8%
Distance to 50-day line
−4.9%
Distance to 200-day line
+1.4%
RSI (14)
32
Volatility 1M
22.8%

Performance

1 week
−5.2%
1 month
−9.9%
3 months
−2.0%
6 months
+5.8%
YTD
+10.0%
1 year
+10.1%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
27 Sep 2026

Frequently asked questions

How has PFE performed since 11/2016?

$10,000 grew to $14,495 by 20 Nov 2026, which is +3.8% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is PFE?

Volatility was 23.0% per year, measured on monthly returns. The largest decline from a peak was −59.0%, with the low in 04/2025.

How does PFE compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, PFE returned +3.8% at 23.0%. The correlation of monthly returns was 0.34; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Pfizer Inc (PFE): Return and risk | Portfolio Lab